Table 3.
Dose-response growth inhibition study with 7c.
| Cell line | GI50 (μM) |
|---|---|
| A549 | 6.4 ± 3.0 |
| AsPC1 | 17.3 ± 0.9 |
| HT29 | 12.1 ± 7.4 |
| MDA-MB-231 | 8.4 ± 0.9 |
| PC3 | 5.9 ± 2.7 |
| SKOV3 | 16.8 ± 5.2 |
| U2OS | 10.8 ± 0.2 |
Dose-response growth inhibition study with 7c.
| Cell line | GI50 (μM) |
|---|---|
| A549 | 6.4 ± 3.0 |
| AsPC1 | 17.3 ± 0.9 |
| HT29 | 12.1 ± 7.4 |
| MDA-MB-231 | 8.4 ± 0.9 |
| PC3 | 5.9 ± 2.7 |
| SKOV3 | 16.8 ± 5.2 |
| U2OS | 10.8 ± 0.2 |